Adjuvant Ribociclib and Endocrine Therapy: A Paradigm Shift in Early Stage HR+/HER2- Breast Cancer Management
The introduction of ribociclib as an adjuvant treatment for breast cancer has revolutionized patient care, offering new hope for those in the early stages of the disease.